INTRODUCTION
Human platelet factor 4 (PF4) (70-amino-acid residues/ monomer) [1] , which belongs to a family of CXC chemokines [2] , demonstrates various physiological effects: it accelerates thrombin-anti-thrombin complex formation [3] ; stimulates fibroblast attachment to the substrate [4] ; stimulates histamine release from human basophils [5] ; displays chemotactic activity with respect to neutrophils [6] , monocytes [6, 7] , and fibroblasts [8] ; potentiates platelet aggregation [9] and elastase release [10] ; releases lysosomal enzymes from leucocytes [11] ; reverses the immunosuppressive effect of lymphoma cells [12] ; and inhibits megakaryocytopoiesis [13, 14] , angiogenesis [15] , solid tumour growth [16] and vascular endothelial cell migration [17] . Many of these biological activities of PF4 appear to be related to its interaction with cell-surface glycosaminoglycans via a protein surface binding domain.
The best known PF4 activity is its ability to bind strongly to the anticoagulant heparin, a polysulphated glycosaminoglycan. When released by activated platelets during coagulation [18] , PF4 displaces thrombin from heparan sulphate on the surface of endothelial cells [where thrombin is anticoagulant through its accelerated interactions with antithrombin III (AT-Ill), thrombomodulin and protein C] into solution, where thrombin is procoagulant through its interactions with fibrinogen and other clotting factors [3] . PF4 prevents the formation of the ternary complexes between heparin, AT-Ill, and various procoagulant serine proteases that are intermediate in the heparin-accelerated inhibition of proteases by AT-Ill. In its native state, PF4 exists as a tetramer [19] in a complex with a high-molecular-mass proteoglycan carrier [20] . PF4 also binds with unusually high affinity to insolubilized heparin and binds to other less sulphated glycosaminoglycans with lower side-chain proton resonances which map to spatially related rcsidues within a ring of positively charged side chains on the surface of tetrameric PF4-M2. Contrary to PF4-heparin binding models which centre around C-terminal a-helix lysines, this study indicates that a loop containing Arg-20, Arg-22, His-23 and Thr-25, as well as Lys-46 and Arg-49, are even more affected by heparin binding. Site-directed mutagenesis and heparin binding data support these NMR findings by indicating that arginines more than C-terminal lysines, are crucial to the heparin binding process.
affinity [21] . Most of the heparin molecule (75-85 %) is accounted for by a repeating disaccharide unit that consists of L-idopyranosyluronic acid (IdoA) 2-sulphate and 2-deoxy-2-sulphamido-D-glucopyranose (GlcNSO3) 6-sulphate [22] [23] [24] . The balance of the molecule is constituted largely of residues of 2-acetamido-2-deoxy-D-glucose and D-glucuronic acid, although the modes of bonding and distribution within the polymer, as well as their degrees of sulphation, have yet to be established unequivocally. In the presence of an excess of heparin (11 000 Da cut-off), the typical PF4-heparin complex consists of one 36-saccharide-long heparin molecule per protein tetramer [25] , although two hexadecasaccharides also can bind to one PF4 molecule [26] . Since PF4 binds to glycosaminoglycans roughly in order of their negative charge density, that is, heparin > heparan sulphate > dermatan sulphate > chondroitin sulphates > hyaluronic acid [27] , the tetramer transfers easily to more sulphated polysaccharides such as heparin when the carrier complex is released from platelets.
X-ray crystallographic and NMR structural studies of bovine [28] and human [29, 30] tetrameric PF4 show that all monomeric subunits have a three-stranded antiparallel fl-sheet domain on to which is folded an amphipathic C-terminal a-helix and an aperiodic N-terminal domain. The amino acid sequence and general folding pattern of PF4 are shown schematically in Figure 1 . In both human and bovine PF4 crystal structures, the homotetrameric arrangement of A, B, C and D subunits is asymmetric, with symmetric AB and CD dimers associating in a non-symmetric fashion. Substitution of the highly acidic N-terminal decapeptide segment of native human PF4 with the N-terminal sequence from homologous interleukin-8 (IL-8) (see Figure 1 for sequence comparison) results in formation of a symmetric PF4 tetramer (called [30] . The R13O-J Figure 1 Sequence and schematic folding pattern for PF4 and PF4-M2
The complete amino acid sequence for native PF4 is shown. For PF4-M2, 11 N-terminal residues present in native PF4 have been replaced by eight N-terminal residues from homologous IL-8. PF4-M2 N-terminal residues are also shown. Residues 12-70 are identical for both species. In addition, the general folding pattern for both PF4 and PF4-M2 is indicated as described in the text. The two cystine disulphide bonds are shown as open bent bars, and some proposed hydrogen bonds are indicated by arrows.
the same [30] , indicating that this asymmetry in native PF4 may be inconsequential to the heparin-binding process. It has been proposed [1, 25] that two pairs of lysine residues within the C-terminal a-helices of each monomer subunit are important for binding to heparin. Based on this information and assuming that native PF4 associates symmetrically, Cowan et al. [31] proposed a model for heparin binding to PF4, which has the anionic heparin polysaccharide wrapped about the tetramer and running parallel to the C-terminal a-helices. Using the X-ray structure of bovine PF4, which showed the presence of a ring of positive charge (which included the solvent-accessible C-terminal lysines) about the PF4 tetramer, Stuckey et al. [32] proposed an alternative PF4-heparin binding model using a graphically designed heparin molecule and the crystallographic coordinates of the native bovine PF4 tetramer. The Stuckey model of heparin bound to PF4 has the anionic polysaccharide running perpendicular to the a-helix axes wrapped about the tetramer along the ring of positive charge, and salt linked to all four lysines on the helix of each monomer.
In the present study, heparin binding to native PF4 and PF4-M2 is studied by using NMR spectroscopy and mutagenesis. Results generally support the perpendicular PF4-heparin binding model [32] , but indicate that heparin interacts more effectively with the arginines in PF4 and less so with the C-terminal lysines.
MATERIALS AND METHODS
Isolation of recombinant PF4-M2 and native PF4 The synthetic genes for human PF4-M2 chimeric mutant and native PF4 were expressed as non-fusion proteins in Escherichia coli (BL2l DE3) cells and grown at the 2-litre (shake flask) or 10-litre (fermenter) scale. Protein was purified, cleaved and refolded essentially as previously described [33] . Cells were grown for 4 [36] . Protein concentrations also were checked by the methods of Lowry et al. [37] and of Waddell [38] .
NMR spectroscopy PF4-M2, which shows nearly the same heparin-binding activity as native PF4, was used for NMR studies. PF4-M2 forms symmetric tetramers making spectral analysis tractable [30] . Samples for NMR measurements had been lyophilized and redissolved in 'H20 or 2H20 immediately before the experiment. For work in 'H20 solutions, 10% 2H20 was routinely used. The final PF4-M2 concentration was 18 mg/ml. The pH was adjusted to pH 5.9 by adding microlitre increments of NaO2H or 2HCI to a 0.6 ml sample. PF4. This may indicate that two molecules of this lowermolecular-mass heparin bind to one molecule of PF4-M2. This is consistent with the work of Bock et al. [26] Figures 2 and 3 . Figure 5 shows the NH-NH region from NOESY spectra of heparin-bound PF4-M2. As with free PF4-M2 [30] , the C- [48, 49] and may be shifted by indirect effects induced by heparin binding. Ile-64 is part of the C-terminal amphipathic helix and is sandwiched between the helix and the f-sheet core. For that matter, Ile-63, Leu-67 and Leu-68 are about equally shifted for similar reasons. All other shifted resonances belong to solvent-exposed hydrophilic residues, most of which are positively charged. C-terminal a-helix residues Lys-61, Lys-62, Lys-65 and Lys-66 are most often associated with PF4-heparin binding. Chemical shifts for Lys-66 side-chain resonances in the presence of heparin could not be determined, but presumably these too would be shifted. Arg-22, His-23, Thr-25, Lys-31 and Arg-49 resonances are more highly shifted than those of the C-terminal lysines, whereas the others, like Arg-20 and Lys-46, are about equally shifted. Although non-specific heparin binding could contribute to observed chemical shift changes, most major shift changes map to a ring of positivecharged residues on the surface of PF4-M2 (see below) as opposed to other charged residues. On the other hand, the possibility of multiple modes of interaction within this charged ring can not be excluded with the present data. This will be discussed further in the discussion section. Figure 6 shows two views of the PF4-M2 tetramer. The view on the left is centred on the AD-dimer interface. C-terminal ahelices run antiparallel to each other at the top and bottom of this Figure. The van der Waals surfaces of potential heparinbinding residues discussed above are highlighted and labelled. Notice the spatial proximity of these positively charged residues. Although this positively charged band has been pointed out previously in a number of studies, this is the first experimental evidence that heparin interacts with numerous residues in this band. The view on the right-hand side ( Figure 6 ) profiles the ADdimer surface and shows that Arg-20 and Arg-22 are extended into the solvent where more effective contacts with heparin are possible. His-23, Lys-46 and Arg-49 lie in a broad crevice at the AD-dimer interface.
To probe the role of specific positively charged residues in heparin binding further, several site-directed mutants were made at Arg-20, Arg-22, Arg-49, Lys-61, Lys-62, Lys-65 and Lys-66. For the C-terminal a-helix domain, alanine was substituted for lysine as single, double and quadruple substitutions. This generated six mutants: K61A, K62A, K65A, K66A, K61,65A and K61,62,65,66A. Alanine was chosen to preserve high helix tendency [50] . Additionally, the KKIIKK sequence was replaced with QEIIQE to provide some opposite charge character to the positively charged band in PF4. In another mutant, Arg-20, Arg-22 and Arg-49 were simultaneously substituted with glutamines.
For all mutants, proper folding was assessed by CD and NMR data comparisons (results not shown) with PF4 and PF4-M2. From TOCSY and NOESY spectral comparisons, for example, the presence or absence off-sheet and C-terminal a-helix folding could be readily determined by chemical shift dispersion and NOE patterns. [54] [55] [56] , while the GlcN 6-0-sulphates are redundant, neither it K66A, solid diamond; PF4 mutant K61,65A, solid triangles (down); PF4 mutant contributing to nor interfering with FGF-2 binding [54] [55] [56] .
,66A, solid triangles (up); PF4 mutant R -+0, solid circle. These designations In contrast, binding of hepatocyte growth factor to heparin/ J to PF4 species listed in Table 1 and described in the text. heparan sulphate appears to depend primarily on GlcN 6-0-sulphates [57] . While part of the PF4-heparin interaction may be of a non-specific nature, at least some of the binding may be inal lysines are less important to heparin binding than promoted by specific interactions with arginine residues on PF4. Lsly thought.
Analysis of the structures of bovine [28] and human [29, 30] ition of salt, i.e. NaCl, up to 0.5 M has a significant effect PF4 indicates that a ring of positive charge runs about the PF4 heparin binding of the arginine-substituted mutant, but tetramer, orthogonal to the C-terminal a-helix axis. Stuckey et on that of the lysine-substituted mutant PF4 al. [32] have proposed that this ring forms the heparin-binding !,65,66A. For the lysine-substituted mutant, binding dedomain in PF4. This present study provides direct evidence that about 8-9-fold, whereas for the arginine-substituted heparin does indeed interact with residues in this ring. As noted it decreased more than 20-fold. Considering that the net above, however, the four C-terminal a-helix lysines are not the charge changed more with the lysine-substituted mutant most perturbed on binding heparin. For some time, chemical ines/tetramer relative to 12 arginines/tetramer), this modification studies of PF4 positively charged groups [25] have ation argues for a greater influence of arginines in modu-been interpreted to indicate that these four C-terminal lysine heparin binding, residues form the PF4 heparin-binding domain. In fact, the ing said this, results with the C-terminal QEIIQE mutant present mutagenesis studies indicate that arginines are more S expressed and folds very well, were puzzling since at first effective than lysines at binding heparin. Both mutants, however, these heparin-binding data could be used to argue for the are still capable of binding heparin, albeit with weaker affinities.
ance of C-termbial lysines. However, in terms of the PF4-This supports the idea that several spatially related (as opposed ucture [30] (and that of PF4 [52] ), Glu-62 and Glu-66 to sequentially related) PF4 residues are necessary for heparin be proximal to Arg-20 and Arg-22 as shown in Figure 6 binding. Furthermore, increased ionic strength lowers the and Lys-66). Direct electrostatic interactions, either heparin affinity for the PF4 Arg -Gln mutant about 10-100-ye between these charged groups in PF4 (salt bridge fold more than for the PF4 K61,62,65,66A mutant. This indicates ion) or repulsive between Glu-62/Glu-66 and heparin, that lysines may interact with heparin more non-specifically than ccount for reduced heparin binding, do arginines.
Cardin and Weintraub [58] [61] , that the key amino acids comprising heparin-binding risons of NOEs are not reliable since the heparin used is domains are located in different peptide sequences that are geneous and may cause differential perturbations. The spatially proximal. As a result of the tertiary structure of the try of PF4-M2 tetramer [30] may even be broken by protein, such sequences converge to form a composite glycosa binding, albeit minimally since spectral perturbations aminoglycan-binding site. This includes the ring of positive inor. Native bovine [28] and human [29] PF4s form charge in PF4 noted above. etric tetramers, while PF4-M2 [30] forms symmetric
One of the key findings in this study is the observation that the ers. Since PF4-M2 binds heparin almost as well as PF4 arginine guanidino groups promote stronger PF4-heparin inter- [ 63] , who indicated that the His-23 pKa shifted significantly when bovine PF4 bound to heparin. This PKa shift, however, may simply be a consequence of heparin binding to Arg-20 and Arg-22 that are proximal to His-23. Gelman et al. [64] [65] [66] demonstrated that polyarginine a-helix denatured at a higher temperature when binding to glycosaminoglycans than an analogous polylysine polymer [64] . GRG has been shown to preferentially interact with the uronic acid residue of heparin disaccharide and not to the more sulphated glucosamino residue (D. Mikhailov, K. H. Mayo, A. Pervin and R. J. Lindhardt, unpublished work), while GKG interacts non-selectively. From analysis of heparintripeptide equilibrium binding isotherms, Mascotti and Lohman [68] found that the tripeptides KWK and RWR bound heparin with association binding constants of 7.0 x 103 M-1 and 13 x 103 M-1 respectively. RWR bound heparin about 2-fold stronger than did KWK. Fromm et al. (J. R. Fromm, R. E. Hileman, E. E. 0. Caldwell, J. M. Weiler and R. J. Linhardt, unpublished work) discovered that even blocked arginines bind more tightly to heparin than do blocked lysines, suggesting that hydrogen bonding of the arginine guanidino group to heparin plays a role in the binding process. Mascotti and Lohman [68] also concluded that arginines most likely participate in more extensive hydrogen bonding interactions with heparin. Arginines are also essential for the binding of thrombin and AT-Ill to heparin [70, 71] . Arginines may have a structural feature in their basic side chain that enhances binding.
In structurally homologous phosphoryl-cation interactions, arginine also plays a more important role than does lysine or histidine. Conserved protein domains that bind phosphotyrosine (SH2 domains) contain more arginine than lysine residues [72, 73] presumably due to the avid interaction of arginine with phosphoryl anions, compared with the interaction of lysine with the phosphoryl anion. From X-ray crystallographic and computer modelling studies ( [74] ; J. R. Fromm, R. E. Hileman, E. E. 0. Caldwell, J. M. Weiler and R. J. Linhardt, unpublished work), it is apparent that guanidino groups can form fewer, albeit stronger, hydrogen bonds with sulphates/phosphates than do ammonium cations. The guanidino cation rather than the ammonium cation may form an inherently stronger electrostatic interaction with the sulphate anion. In the context of Pearson's concept of soft acid, soft base interactions [75] , arginine, a large diffuse cation (soft), is ideally suited to interact with large (soft) bio-anions, such as sulphate and phosphate. Riordan and co-workers [76] suggest that in nature, arginyl residues play a unique role in anion recognition. It has even been suggested that arginine appeared later in evolution to perform important biological functions [76] [77] [78] .
The PF4-M2 residues which are most chemically shifted by the binding to heparin lie within the ring of positive charge noted above. This is consistent with the PF4-heparin perpendicular (with respect to the C-terminal oc-helix axis) binding model of Stuckey et al. [32] and refutes the original Cowan et al. [31] parallel binding model. The Stuckey et al. model [32] , however, the bovine PF4 complex and relies heavily on interactions with all four lysines. If this were so, one would expect to observe more significant chemical shift and PF4-mutant heparin binding changes for the C-terminal lysines.
Stuckey et al. [32] modelled the PF4-heparin interaction by centring the heparin chain on the C-terminal a-helix lysines, i.e. the C2 axis of symmetry of the AB dimer. The heparin molecule could bind to the helix bundle at some angle between the two limiting orientations, i.e. parallel or perpendicular, or could bind centrosymmetrically differently. An alternative mode of binding would have the heparin chain centred at the AD-dimer C2 symmetry axis. In this respect, the arginines and other important heparin-binding residues identified here would lie near the centre of this dimer and the C-terminal lysines would lie at the top and bottom of the AD-type dimer. This would better explain chemical shift perturbations and the fact that heparin binding is not highly perturbed by replacement of the C-terminal lysines. This possible novel orientation also agrees with the observations of Bock et al. [26] that PF4 binds two hexadecamers of heparin when the heparin fragments are in excess but only one molecule of larger heparins. A heparin molecule of 16 saccharide units still can bind one AD-type dimer without interfering with the other site; larger heparin molecules wrap around PF4 and occupy both sites. The inherent stability of the AB-type dimers [29, 30] would help hold the tetrameric complex together. AC-and AD-type dimer interactions are considerably weaker than AB-type dimer interactions [19, 28] . Resolution of this will have to await a highresolution structure of the PF4-heparin complex. In particular, intermolecular protein-heparin NOEs need to be identified. In the present study, intermolecular proton-proton NOEs were not apparent for two possible reasons: (1) the presence of heterogeneous heparin and the possibility of multiple protein-heparin interactions; and (2) the dominance of electrostatic Coulombic binding forces, which may lead to large interproton distances between heparin and PF4-M2 and therefore to attenuated or absent intermolecular proton-proton NOEs.
Most of the basic residues identified here that interact with heparin are conserved in other members of the PF4 superfamily that are known to bind heparin [79] , notably platelet basic protein, IL-8 and GRO-a. Stuckey et al. [32] have pointed out that the strength of the interaction generally correlates with the degree of conservation of the basic residues. Mayo [80] proposed that the aggregate state, i.e. monomer, dimer or tetramer, of the particular chemokine also contributes to the strength of glycosaminoglycan binding to the protein. This is one reason why tetrameric PF4 binds heparin more strongly than mostly monomeric platelet basic protein-related chemokines [33] . In the present study, the reduction of the net positive charge on tetrameric PF4 mutants affects heparin binding only slightly in some cases. If charge alone were responsible for the strength of heparin binding, then larger effects on PF4-heparin binding would have resulted.
Out of 11 CXC chemokines (sequences shown in Stuckey et al.
[32] Figure 6 ), the loop 19-24 always begins and ends with a hydrophobic residue; residue 21 is always Pro (8/11) (8/11) . Lastly, the amphipathic C-terminal helix maintains a high incidence of lysines in all these species.
In summary, three conclusions can be drawn from this study: (1) PF4 can bind heparin even with the removal of some positively charged residues, (2) arginines are important for heparin binding, and (3) C-terminal lysines are less important to heparin binding than previously thought.
